Stem cell‐based therapy for Parkinson’s disease with a focus on human endometrium‐derived mesenchymal stem cells
- 26 August 2018
- journal article
- review article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (2) , 1326-1335
Abstract
Parkinson’s disease (PD) as an increasing clinical syndrome is a multifunctional impairment with systemic involvement. At present, therapeutic approaches such as l ‐3,4‐dihydroxy‐phenylalanine replacement therapy, dopaminergic agonist administration, and neurosurgical treatment intend to relieve PD symptoms which are palliative and incompetent in counteracting PD progression. These mentioned therapies have not been able to replace the lost cells and they could not effectively slow down the relentless neurodegenerative process. Till now, there is a lack of eligible treatment for PD, and stem cells therapy recently has been considered for PD treatment. In this review, we demonstrate how human stem cell technology especially human endometrium‐derived stem cells have made advancement as a therapeutic source for PD compared with other treatments.Keywords
This publication has 108 references indexed in Scilit:
- Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton’s Jelly to Dopamine Neurons Mediated by the Lmx1a and Neurturin In Vitro: Potential Therapeutic Application for Parkinson’s Disease in a Rhesus Monkey ModelPLOS ONE, 2013
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s diseaseNature, 2011
- Isolation and Culture of Epithelial Progenitors and Mesenchymal Stem Cells from Human Endometrium1Biology of Reproduction, 2009
- Striatal Plasticity and Basal Ganglia Circuit FunctionNeuron, 2008
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cellsProceedings of the National Academy of Sciences, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Stem cells for the treatment of neurological disordersNature, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006